Table 1.
Variables | pNEN (n = 52) | PDAC (n = 18) | p value |
---|---|---|---|
Patient characteristics | |||
Age (median, range) | 56.0, 31–77 | 69.5, 46–77 | 0.001 |
≤60 | 32 | 4 | 0.004 |
60< | 20 | 14 | |
Gender | |||
Female | 29 | 10 | 0.987 |
Male | 23 | 8 | |
Tumour size (median, range) (mm) | 19.5, 6–92 | 25.5, 10–120 | 0.155 |
≤20 | 27 | 5 | 0.076 |
20< | 25 | 13 | |
Lymph node metastasis | 17 | 9 | 0.190 |
lymphatic invasion (ly) | 16 | 12 | 0.007 |
vascular invasion (v) | 29 | 17 | 0.003 |
perineural invasion (ne) | 18 | 18 | <0.001 |
Tumour Location | |||
Ph | 20 | 10 | 0.387 |
Pbt | 30 | 7 | |
Phbt | 2 | 1 | |
Surgical Procedure | |||
Enucleation | 6 | 0 | 0.041 |
Pancreatoduodenectomy | 16 | 10 | |
Distal pancreatectomy | 29 | 6 | |
Total pancreatectomy | 1 | 2 | |
Grade (WHO 2017) | |||
G1 | 32 | ||
G2 | 15 | ||
G3 | 3 | ||
NEC | 2 | ||
pStage (7th-UICC) | |||
IA | 17 | 0 | |
IB | 10 | 1 | |
IIA | 8 | 7 | |
IIB | 14 | 9 | |
III | 0 | 1 | |
IV | 3 | 0 | |
pStage (ENETS) | |||
I | 18 | 3 | |
IIA | 11 | 3 | |
IIB | 6 | 3 | |
IIIA | 0 | 0 | |
IIIB | 14 | 9 | |
IV | 3 | 0 |
Pearson’s chi-squared tests were used to compare age, sex, tumour size, lymph node metastasis, lymphatic invasion, vascular invasion, perineural invasion, tumour location, and surgical procedure. Mann-Whitney U tests were used to compare age and tumour size.